23,338,039
Vote Records
27,979
Companies
11,817
Funds
4,051
Managers

Home › Companies › Roivant Sciences Ltd. › 2025-2026

Roivant Sciences Ltd. 2025-2026 Proxy Voting Records

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings and Roivant Sciences Ltd.’s Form 8-K, filed September 11, 2025 (Item 5.07 on EDGAR). Page generated November 20, 2026.

  • 5Ballot items
  • 295Asset managers, any item
  • 1,802Fund votes
  • September 10, 2025Meeting date

Results at a glance

Meeting of September 10, 2025: 5 items on Roivant Sciences Ltd.’s Form 8-K, filed September 11, 2025: 3 elected · 2 approved.

Dissent

Significant dissent: 3 directors (29.4%, 26.5%, 26.4% against); 1 say-on-pay vote (60.9% support).

Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Activist investors: Rubric Capital (13F, 1.0%, as of September 30, 2026) · Two Seas Capital LP (13F, 1.0%, as of September 30, 2026)

Explore Roivant Sciences Ltd. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Roivant Sciences Ltd.

These tallies are Roivant Sciences Ltd.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed September 11, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Roivant Sciences Ltd. — official shareholder meeting results, meeting held September 10, 2025
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Matthew Gline 430,013,727---- 154,432,13544,227,813 74%Elected—
Elect Director: Keith Manchester 412,869,513---- 171,576,34944,227,813 71%Elected—
Elect Director: Melissa Epperly 429,542,705---- 154,903,15744,227,813 73%Elected—
2. The appointment of Ernst & Young LLP ("EY") to serve as the Company's independent registered public accounting firm for the fiscal year ending March 31, 2026, and to appoint EY as the Company's auditor for statutory purposes under the Bermuda Com 628,068,956479,264125,455 ---- 99.9%Approveda majority of the votes cast
3. On a non-binding advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement, including the compensation tables and related narrative disclosures 316,651,402203,244,18464,550,276 --44,227,813 61%Approved—

Source: Roivant Sciences Ltd., Form 8-K, filed with the SEC on September 11, 2025 — read the filing on EDGAR.

How asset managers voted at the Roivant Sciences Ltd. 2025-2026 meeting

295 asset managers disclosed a vote on at least one Roivant Sciences Ltd. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.

Elect Director: Matthew Gline

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 9 wordings of this item as funds reported it.

74% Majority: yes · of votes cast

FOR 74%WITHHELD
FOR: 430,013,727WITHHELD: 154,432,135
Details: description as filed, official tally, votes by 71 asset managers

Description as filed by funds: To elect the Board of Directors' three nominees for Class I Director to serve for a three-year term: Matthew Gline

Roivant Sciences Ltd.’s own tally for this item (“Elect Director: Matthew Gline”): 430,013,727 for, 154,432,135 withheld, per its Form 8-K filed September 11, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “(1) Shareholders re-elected the individuals named below to serve as Class I directors of the Company, to hold office until the date of the annual general meeting of shareholders following the fiscal year ending March 31, 2028, and until their successors are duly elected and qualified, or until such…”
Support: 74% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 71 asset managers below reported 93,276,845 for, 34,310,335 withheld, 1,462,797 abstained.

FORWITHHOLD
FOR: 93,276,845ABSTAIN: 1,462,797WITHHOLD: 34,310,335
Largest asset managers voting on “To elect the Board of Directors' three nominees for Class I Director to serve for a three-year term: Matthew G” at Roivant Sciences Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard38,008,3160 80For
Fidelity6,394,7530 027,552,227Mixed
BlackRock17,505,6720 00For
Morgan Stanley8,789,8420 07,964For
State Street4,990,1160 00For
Charles Schwab2,865,3890 00For
TIAA2,217,5210 00For
Transamerica2,078,2770 00For
IMPAX FUNDS SERIES TRUST I2,000,0000 00For
WisdomTree00 01,767,115Withhold
Goldman Sachs1,660,0660 00For
Dimensional00 01,562,980Withhold
Equitable1,526,7040 00For
TIFF INVESTMENT PROGRAM1,403,6990 00For
T. Rowe Price1,047,6640 00For
Jackson National00 782,9010Abstain
Brighthouse575,8350 0157,665Mixed
AIG/SunAmerica00 0571,010Withhold
John Hancock18,4000 404,3330Abstain
Direxion Shares ETF Trust00 0395,758Withhold
Columbia Threadneedle376,6950 00For
Delaware/Macquarie00 0338,181Withhold
JPMorgan294,2920 00For
Northern Trust288,5150 00For
BNY Mellon00 0266,779Withhold

Showing the 25 largest of 71 asset managers. All 71 are in the interactive database (link above).

Elect Director: Keith Manchester

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 9 wordings of this item as funds reported it.

71% Majority: yes · of votes cast

FOR 71%WITHHELD
FOR: 412,869,513WITHHELD: 171,576,349
Details: description as filed, official tally, votes by 71 asset managers

Description as filed by funds: To elect the Board of Directors' three nominees for Class I Director to serve for a three-year term: Keith Manchester

Roivant Sciences Ltd.’s own tally for this item (“Elect Director: Keith Manchester”): 412,869,513 for, 171,576,349 withheld, per its Form 8-K filed September 11, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “(1) Shareholders re-elected the individuals named below to serve as Class I directors of the Company, to hold office until the date of the annual general meeting of shareholders following the fiscal year ending March 31, 2028, and until their successors are duly elected and qualified, or until such…”
Support: 71% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 71 asset managers below reported 87,230,772 for, 40,356,407 withheld, 1,462,798 abstained.

FORWITHHOLD
FOR: 87,230,772ABSTAIN: 1,462,798WITHHOLD: 40,356,407
Largest asset managers voting on “To elect the Board of Directors' three nominees for Class I Director to serve for a three-year term: Keith Man” at Roivant Sciences Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard38,008,3150 90For
Fidelity6,394,7530 027,552,227Mixed
BlackRock17,505,6720 00For
Morgan Stanley8,789,8420 07,964For
State Street00 04,990,116Withhold
Charles Schwab2,865,3890 00For
TIAA2,217,5210 00For
Transamerica2,078,2770 00For
IMPAX FUNDS SERIES TRUST I2,000,0000 00For
WisdomTree00 01,767,115Withhold
Goldman Sachs1,660,0660 00For
Dimensional00 01,562,980Withhold
Equitable1,095,0620 0431,642Mixed
TIFF INVESTMENT PROGRAM1,403,6990 00For
T. Rowe Price1,047,6640 00For
Jackson National00 782,9010Abstain
Brighthouse575,8350 0157,665Mixed
AIG/SunAmerica00 0571,010Withhold
John Hancock18,4000 404,3330Abstain
Direxion Shares ETF Trust00 0395,758Withhold
Columbia Threadneedle376,6950 00For
Delaware/Macquarie00 0338,181Withhold
JPMorgan294,2920 00For
Northern Trust00 0288,515Withhold
BNY Mellon00 0266,779Withhold

Showing the 25 largest of 71 asset managers. All 71 are in the interactive database (link above).

Elect Director: Melissa Epperly

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 9 wordings of this item as funds reported it.

73% Majority: yes · of votes cast

FOR 73%WITHHELD
FOR: 429,542,705WITHHELD: 154,903,157
Details: description as filed, official tally, votes by 71 asset managers

Description as filed by funds: To elect the Board of Directors' three nominees for Class I Director to serve for a three-year term: Melissa Epperly

Roivant Sciences Ltd.’s own tally for this item (“Elect Director: Melissa Epperly”): 429,542,705 for, 154,903,157 withheld, per its Form 8-K filed September 11, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “(1) Shareholders re-elected the individuals named below to serve as Class I directors of the Company, to hold office until the date of the annual general meeting of shareholders following the fiscal year ending March 31, 2028, and until their successors are duly elected and qualified, or until such…”
Support: 73% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 71 asset managers below reported 92,845,203 for, 34,741,977 withheld, 1,462,797 abstained.

FORWITHHOLD
FOR: 92,845,203ABSTAIN: 1,462,797WITHHOLD: 34,741,977
Largest asset managers voting on “To elect the Board of Directors' three nominees for Class I Director to serve for a three-year term: Melissa E” at Roivant Sciences Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard38,008,3160 80For
Fidelity6,394,7530 027,552,227Mixed
BlackRock17,505,6720 00For
Morgan Stanley8,789,8420 07,964For
State Street4,990,1160 00For
Charles Schwab2,865,3890 00For
TIAA2,217,5210 00For
Transamerica2,078,2770 00For
IMPAX FUNDS SERIES TRUST I2,000,0000 00For
WisdomTree00 01,767,115Withhold
Goldman Sachs1,660,0660 00For
Dimensional00 01,562,980Withhold
Equitable1,095,0620 0431,642Mixed
TIFF INVESTMENT PROGRAM1,403,6990 00For
T. Rowe Price1,047,6640 00For
Jackson National00 782,9010Abstain
Brighthouse575,8350 0157,665Mixed
AIG/SunAmerica00 0571,010Withhold
John Hancock18,4000 404,3330Abstain
Direxion Shares ETF Trust00 0395,758Withhold
Columbia Threadneedle376,6950 00For
Delaware/Macquarie00 0338,181Withhold
JPMorgan294,2920 00For
Northern Trust288,5150 00For
BNY Mellon00 0266,779Withhold

Showing the 25 largest of 71 asset managers. All 71 are in the interactive database (link above).

On a non-binding advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy…

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 4 wordings of this item as funds reported it.

61% Approved · of votes cast

FOR 61%AGAINST
FOR: 316,651,402AGAINST: 203,244,184

Prior year: 89.3% for (September 10, 2024 meeting) ▼ 28.4 pts

Details: description as filed, official tally, votes by 294 asset managers

Description as filed by funds: To cast a non-binding, advisory vote to approve the compensation of our named executive officers.

Roivant Sciences Ltd.’s own tally for this item (“3. On a non-binding advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement, including the compensation tables and related narrative disclosures”): 316,651,402 for, 203,244,184 against — passed, per its Form 8-K filed September 11, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “(3) Shareholders approved, on a non-binding advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement, including the compensation tables and related narrative disclosures.”
Support: 61% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 71 asset managers voting on “To cast a non-binding, advisory vote to approve the compensation of our named executive officers.” at Roivant Sciences Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard5,82938,002,496 00Against
Fidelity033,946,980 00Against
BlackRock1,344,55716,161,115 00Mixed
Morgan Stanley8,789,8427,964 00For
State Street04,990,116 00Against
Charles Schwab02,865,389 00Against
TIAA2,217,5210 00For
Transamerica2,078,2770 00For
IMPAX FUNDS SERIES TRUST I2,000,0000 00For
WisdomTree01,767,115 00Against
Goldman Sachs1,660,0660 00For
Dimensional01,562,980 00Against
Equitable925,183601,521 00Mixed
TIFF INVESTMENT PROGRAM01,403,699 00Against
T. Rowe Price01,047,664 00Against
Jackson National0782,901 00Against
Brighthouse575,835157,665 00Mixed
AIG/SunAmerica0571,010 00Against
John Hancock0422,733 00Against
Direxion Shares ETF Trust0395,758 00Against
Columbia Threadneedle0376,695 00Against
Delaware/Macquarie0338,181 00Against
JPMorgan0294,292 00Against
Northern Trust0288,515 00Against
BNY Mellon0266,779 00Against

Fund voting reports, all 71 managers: 19,804,659 for, 109,161,237 against, 84,082 abstained. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 245 asset managers voting on “To cast a non-binding, advisory vote to approve the compensation of our named executive officers.” at Roivant Sciences Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
SB INVESTMENT ADVISERS (UK) LTD00 59,036,5710Abstain
Fidelity053,201,296 00Against
VIKING GLOBAL INVESTORS LP30,322,0470 00For
QVT Financial LP29,381,6350 00For
Morgan Stanley27,768,7730 00For
State Street7,59513,133,518 00Against
BlackRock336,22812,110,509 00Against
GEODE CAPITAL MANAGEMENT, LLC07,443,269 00Against
Two Seas Capital LP5,885,5230 00For
Capital Group00 4,832,6420Abstain
PERCEPTIVE ADVISORS LLC3,162,9480 00For
Point7203,080,715 00Against
Rubric Capital Management LP2,949,9220 00For
Charles Schwab02,923,949 00Against
Woodline Partners LP2,508,8920 00For
Northern Trust02,480,155 00Against
Polar Capital Holdings Plc02,450,000 00Against
ORBIMED ADVISORS LLC02,278,760 00Against
Nuveen2,264,7980 00For
DME Capital Management, LP2,208,9200 00For
Sofinnova Investments, Inc.02,084,636 00Against
MELLON INVESTMENTS Corp02,024,948 00Against
IMPAX ASSET MANAGEMENT LLC02,000,000 00Against
Clearbridge Investments, LLC01,860,540 00Against
T. Rowe Price01,830,527 00Against

Institutional-manager reports, all 245 managers: 114,302,908 for, 127,211,137 against, 63,894,716 abstained, 4,971 not voted. Showing the 25 largest; every one is in the interactive database (link above).

The appointment of Ernst & Young LLP ("EY") to serve as the Company's independent registered public accounting firm for…

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 3 wordings of this item as funds reported it.

99.9% Approved · of votes cast

FOR 99.9%
FOR: 628,068,956AGAINST: 479,264

Prior year: 99.9% for (September 10, 2024 meeting) unchanged

Details: description as filed, official tally, votes by 69 asset managers

Description as filed by funds: To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as Roivant's independent registered public accounting firm for Roivant's fiscal year ending March 31, 2026, to appoint Ernst & Young LLP as auditor for statutory purposes under the Bermuda Companies Act 1981, as amended, for Roivant's fiscal year ending March 31, 2026, and to authorize the Board of Directors, through the Audit Committee, to set the remuneration for Ernst & Young LLP as Roivant's auditor for Roivant's fiscal year ending March 31, 2026.

Roivant Sciences Ltd.’s own tally for this item (“2. The appointment of Ernst & Young LLP ("EY") to serve as the Company's independent registered public accounting firm for the fiscal year ending March 31, 2026, and to appoint EY as the Company's auditor for statutory p”): 628,068,956 for, 479,264 against — passed, per its Form 8-K filed September 11, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “(2) Shareholders ratified the appointment of Ernst & Young LLP ("EY") to serve as the Company's independent registered public accounting firm for the fiscal year ending March 31, 2026, and to appoint EY as the Company's auditor for statutory purposes under the Bermuda Companies Act 1981, as amended…”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Voting standard, as the filing states it: a majority of the votes cast (“majority of the votes cast”).

Also reported under other wordings, matched to the same row of Roivant Sciences Ltd.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Approve Ernst & Young LLP as Auditors and Authorize Board to Fix Their Remuneration” (4 managers, 510,219 for).

The 69 asset managers below reported 128,455,676 for, 174,310 abstained.

FOR
FOR: 128,455,676ABSTAIN: 174,310
Largest asset managers voting on “To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as Roivant's ind” at Roivant Sciences Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard38,008,3240 00For
Fidelity33,946,9800 00For
BlackRock17,505,6720 00For
Morgan Stanley8,797,8060 00For
State Street4,990,1160 00For
Charles Schwab2,865,3890 00For
TIAA2,217,5210 00For
Transamerica2,078,2770 00For
IMPAX FUNDS SERIES TRUST I2,000,0000 00For
WisdomTree1,767,1150 00For
Goldman Sachs1,660,0660 00For
Dimensional1,562,9800 00For
Equitable1,526,7040 00For
TIFF INVESTMENT PROGRAM1,403,6990 00For
T. Rowe Price1,047,6640 00For
Jackson National782,9010 00For
Brighthouse733,5000 00For
AIG/SunAmerica571,0100 00For
John Hancock422,7330 00For
Direxion Shares ETF Trust395,7580 00For
Columbia Threadneedle376,6950 00For
Delaware/Macquarie338,1810 00For
Northern Trust288,5150 00For
BNY Mellon266,7790 00For
Bridge Builder Trust252,0130 00For

Showing the 25 largest of 69 asset managers. All 69 are in the interactive database (link above).

Largest Roivant Sciences Ltd. shareholders voting in 2025-2026

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 682,229,832 shares outstanding at the time of that meeting.

Fund voting reports: top Roivant Sciences Ltd. shareholders by shares voted on “To cast a non-binding, advisory vote to approve the compensation of our named executive…”, 2025-2026
#Asset manager % of shares outstanding
1Vanguard 5.57%
2Fidelity 4.98%
3BlackRock 2.57%
4Morgan Stanley 1.29%
5State Street 0.73%
6Charles Schwab 0.42%
7TIAA 0.33%
8Transamerica 0.30%
9IMPAX FUNDS SERIES TRUST I 0.29%
10WisdomTree 0.26%
Institutional-manager reports: top Roivant Sciences Ltd. shareholders by shares voted on “To cast a non-binding, advisory vote to approve the compensation of our named executive…”, 2025-2026
#Asset manager % of shares outstanding
1SB INVESTMENT ADVISERS (UK) LTD 8.65%
2Fidelity 7.80%
3VIKING GLOBAL INVESTORS LP 4.44%
4QVT Financial LP 4.31%
5Morgan Stanley 4.07%
6State Street 1.93%
7BlackRock 1.82%
8GEODE CAPITAL MANAGEMENT, LLC 1.09%
9Two Seas Capital LP 0.86%
10Capital Group 0.71%

Reported Roivant Sciences Ltd. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.

Roivant Sciences Ltd. holdings and ownership disclosed for the 2025-2026 proxy season, with each row’s source and date
HolderShares % outstandingSource, as of
Dexxon Holdings102,849,443 15.08%Proxy statement (DEF 14A), table as of June 30, 2026
FMR (Fidelity)77,981,253 11.43%Form 13F, quarter ended March 31, 2026
FMR LLC73,641,253 10.79%Proxy statement (DEF 14A), table as of June 30, 2026
BlackRock44,254,260 6.49%Form 13F, quarter ended March 31, 2026
Vanguard Group42,059,041 6.16%Form 13F, quarter ended March 31, 2026
Morgan Stanley40,693,386 5.96%Schedule 13G, filed August 13, 2026
Ramaswamy Vivek25,534,970 3.74%Schedule 13G, filed May 6, 2026
Mayukh Sukhatme President and Chief Investment Officer and Director20,104,996 2.95%Proxy statement (DEF 14A), table as of June 30, 2026
Matthew Gline Chief Executive Officer and Director18,758,353 2.75%Proxy statement (DEF 14A), table as of June 30, 2026
SB Investment Advisers (UK) Limited16,413,603 2.41%Schedule 13G, filed February 17, 2026

Percentages above are of 682,229,832 shares outstanding, as reported by Roivant Sciences Ltd. on its Form 10-Q dated June 30, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this meeting

At Roivant Sciences Ltd.'s shareholder meeting held September 10, 2025, in the 2025-2026 proxy season, 295 asset managers reported votes on at least one of its 5 ballot items in their SEC Form N-PX filings, covering 1,802 separate fund positions. On the most widely held item on that ballot — To cast a non-binding, advisory vote to approve the compensation of our named executive… — Roivant Sciences Ltd.'s filing reports the proposal as approved, with 61% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Roivant Sciences Ltd.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on September 11, 2025.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Roivant Sciences Ltd.’s 10-Q dated June 30, 2025. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.

Roivant Sciences Ltd. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).

Cite this page

Proxy Votes Now, “Roivant Sciences (ROIV) 2025 Annual Meeting (2025-2026 season)”, https://proxyvotesnow.com/company/roivant-sciences-ltd/2026 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.